The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBodycote Regulatory News (BOY)

Share Price Information for Bodycote (BOY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 679.00
Bid: 683.00
Ask: 691.00
Change: -15.00 (-2.16%)
Spread: 8.00 (1.171%)
Open: 691.00
High: 703.00
Low: 679.00
Prev. Close: 694.00
BOY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

US TAX LEGISLATION AND TRADING UPDATE

15 Jan 2018 07:00

RNS Number : 8079B
Bodycote PLC
15 January 2018
 

15 January 2018

 

Bodycote plc

 

US TAX LEGISLATION AND TRADING UPDATE

 

Bodycote, the world's largest provider of heat treatment and specialist thermal processing services issues the following tax and trading update for the year to 31 December 2017.

 

US Tax Legislation

 

Bodycote notes the enactment of the Tax Cuts and Jobs Act in the United States on 22 December 2017 reducing the statutory rate of US Federal corporate income tax to 21%. Whilst work is ongoing to review the full future impact of this new US tax legislation on the Group, it is expected to give rise to a significant non-cash tax credit for the Group in the year ended 31 December 2017 as a result of the revaluation of US net deferred tax liabilities. 

 

Subject to final audit and confirmation of final tax computations, the effect of this one-off revaluation of US net deferred tax liabilities is expected to add c. 5p to EPS for 2017.

 

Trading Update

 

Bodycote also announces that trading in the final quarter of 2017 was better than anticipated and the Board now expects full year 2017 headline operating profit to be towards the upper end of market expectations (company compiled analysts' estimates range: £117 million - £126 million).

 

Bodycote intends to announce Full Year Results on Tuesday 6 March 2018.

 

- END -

 

 

 

 

For further information, please contact:

 

Bodycote plc

Tel No +44(0) 1625 505300

Stephen Harris, Group Chief Executive

Dominique Yates, Chief Financial Officer

Fiona Lawrence, Head of Investor Relations

FTI Consulting

Tel No +44 (0) 2037271340

Richard Mountain

Susanne Yule

 

 

About Bodycote

With more than 180 accredited facilities in 23 countries, Bodycote is the world's largest provider of heat treating and specialist thermal processing services. Through classical heat treatment and specialist technologies including Hot Isostatic Pressing (HIP), Bodycote improves the properties of metals and alloys, extending the life of vital components for a wide range of industries, including aerospace, defence, automotive, power generation, oil & gas, construction, medical and transportation. Customers in all of these industries have entrusted their products to Bodycote's care for more than 30 years. For more information, visit www.bodycote.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEAPFLFLXPEFF
Date   Source Headline
22nd Apr 20247:00 amPRNTransaction in Own Shares
19th Apr 20247:00 amPRNTransaction in Own Shares
18th Apr 20247:00 amPRNTransaction in Own Shares
17th Apr 20247:00 amPRNTransaction in Own Shares
16th Apr 20247:00 amPRNTransaction in Own Shares
15th Apr 20247:00 amPRNTransaction in Own Shares
12th Apr 20247:00 amPRNTransaction in Own Shares
11th Apr 20247:00 amPRNTransaction in Own Shares
10th Apr 20247:00 amPRNTransaction in Own Shares
9th Apr 20247:00 amPRNTransaction in Own Shares
8th Apr 20247:00 amPRNTransaction in Own Shares
5th Apr 20247:00 amPRNTransaction in Own Shares
4th Apr 20249:50 amPRNAnnual Financial Report
4th Apr 20247:00 amPRNTransaction in Own Shares
3rd Apr 20247:00 amPRNTransaction in Own Shares
2nd Apr 20249:47 amPRNHolding(s) in Company
2nd Apr 20249:41 amPRNHolding(s) in Company
2nd Apr 20248:35 amPRNTransaction in Own Shares
28th Mar 20247:00 amPRNTransaction in Own Shares
27th Mar 20247:00 amPRNTransaction in Own Shares
26th Mar 20247:00 amPRNTransaction in Own Shares
25th Mar 20243:07 pmPRNDirector/PDMR Shareholding
25th Mar 20247:00 amPRNTransaction in Own Shares
22nd Mar 20247:00 amPRNTransaction in Own Shares
21st Mar 20242:55 pmPRNDirector/PDMR Shareholding
21st Mar 20242:29 pmPRNDirector/PDMR Shareholding
21st Mar 20247:00 amPRNTransaction in Own Shares
20th Mar 20247:00 amPRNTransaction in Own Shares
19th Mar 202411:24 amPRNDirector/PDMR Shareholding
19th Mar 20247:00 amPRNTransaction in Own Shares
18th Mar 20247:00 amPRNTransaction in Own Shares
15th Mar 20247:10 amRNSLaunch of £60 million Share Buyback Programme
15th Mar 20247:00 amRNSFull year results for year ended 31 December 2023
11th Mar 20247:00 amPRNBoard Change
1st Mar 20249:27 amPRNDirector Declaration
29th Feb 20244:30 pmPRNTotal Voting Rights
31st Jan 20244:30 pmPRNTotal Voting Rights
31st Jan 20243:57 pmPRNBodycote plc - Holding(s) in Company
22nd Jan 20247:00 amRNSAcquisition Update and Share Buyback Programme
8th Jan 20244:37 pmPRNHolding(s) in Company
29th Dec 202312:25 pmPRNTotal Voting Rights
8th Dec 20234:40 pmPRNDirector/PDMR Shareholding
30th Nov 20234:30 pmPRNTotal Voting Rights
22nd Nov 20237:00 amRNSTrading Update
10th Nov 202312:08 pmPRNDirector/PDMR Shareholding
9th Nov 20237:00 amRNSDirector Declaration
31st Oct 20234:30 pmPRNTotal Voting Rights
31st Oct 202310:07 amPRNDirector/PDMR Shareholding
18th Oct 20237:00 amRNSGroup Chief Executive Appointment
9th Oct 20237:00 amRNSSpecialist Tech Acquisitions & New HIP Facility

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.